| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 315,573 | 219,499 | ||
| Short-term investments | 50,855 | 101,220 | ||
| Accounts receivable | 47,826 | 50,814 | ||
| Supplies and inventory | 20,327 | 25,020 | ||
| Prepaid expenses and other current assets | 14,643 | 18,128 | ||
| Total current assets | 449,224 | 414,681 | ||
| Property, plant and equipment, net | 18,900 | 18,552 | ||
| Right-of-use assets, operating leases | 37,301 | 38,679 | ||
| Total | 86,277 | - | ||
| Indefinite-lived intangible assets | 6,200 | - | ||
| Intangible assets, net | 92,477 | 95,806 | ||
| Goodwill | 767,154 | 773,255 | ||
| Restricted cash | 1,637 | 1,654 | ||
| Other assets | 1,094 | 1,477 | ||
| Total assets | 1,367,787 | 1,344,104 | ||
| Accounts payable | 5,509 | 11,447 | ||
| Accrued liabilities | 48,373 | 43,707 | ||
| Current portion of deferred revenue | 417 | 1,450 | ||
| Current portion of acquisition-related contingent consideration | 13,571 | 13,415 | ||
| Current portion of operating lease liabilities | 4,282 | 6,414 | ||
| Current portion of other liabilities | 0 | 0 | ||
| Total current liabilities | 72,152 | 76,433 | ||
| Deferred tax liabilities | 1,214 | 1,301 | ||
| Acquisition-related contingent consideration, net of current portion | 583 | 573 | ||
| Operating lease liabilities, net of current portion | 36,171 | 44,232 | ||
| Other liabilities | 0 | 508 | ||
| Total liabilities | 110,120 | 123,047 | ||
| Common stock, 0.001 par value 125,000,000 shares authorized, 79,034,078 and 77,772,678 shares issued and outstanding as of september30, 2025 and december31, 2024, respectively | 79 | 79 | ||
| Additional paid-in capital | 1,684,587 | 1,670,853 | ||
| Accumulated deficit | -418,779 | -437,916 | ||
| Accumulated other comprehensive loss | -8,220 | -11,959 | ||
| Total stockholders equity | 1,257,667 | 1,221,057 | ||
| Total liabilities and stockholders equity | 1,367,787 | 1,344,104 | ||
VERACYTE, INC. (VCYT)
VERACYTE, INC. (VCYT)